FDA 483 - Rush University Medical Center Blood Center - February 21, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Rush University Medical Center Blood Center 262 Jelke in Chicago, IL, identified significant compliance issues. The facility failed to report numerous biological product deviations within the required 45-day timeframe and was found to have missing biological product deviation records. Additionally, the inspection revealed a lack of official training for the Quality Assurance Coordinator responsible for verifying, documenting, and submitting these critical reports.
- Inspection Date
- February 21, 2017
- Product Type
- Biologics
ID · 6e398408-dd55-484d-bd92-70d958297df2